9 Redox nanotechnology and glutathione-responsive therapies Redox nanotechnology leverages the abnormal oxidativereductive balance found in tumors to enable precise, stimulus-responsive treatments
Several animal studies conducted in diabetic and non-diabetic rodent models of focal cerebral ischemia reported an improvement in redox status parameters following administration of exenatide, liraglutide, or lixisenatide, with reduced levels of cerebral malondialdehyde (MDA) and increased cerebral concentrations of glutathione and superoxide dismutase (SOD) [73, 85,86,87]
WARNING:Use sunscreen after using this product and/or avoid direct sun
In other words, to support both detox pathways, the liver needs to be given an abundance of vitamins and nutrients
Furuno T, Yamasaki F, Yokoyama T, Sato K, Sato T, Doi Y, et al